MLYS Archived Articles

Mineralys Therapeutics (NASDAQ:MLYS): A Clinical-Stage Biotech Targeting Hypertension and Related Conditions


Mineralys Therapeutics, Inc. (NASDAQ:MLYS): Pioneering Targeted Therapies for Cardiorenal Diseases


Mineralys Therapeutics, Inc. (NASDAQ:MLYS): A Promising Aldosterone-Targeting Approach to Cardiorenal Diseases